1. Home
  2. BOLT vs GRRR Comparison

BOLT vs GRRR Comparison

Compare BOLT & GRRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLT
  • GRRR
  • Stock Information
  • Founded
  • BOLT 2015
  • GRRR 2001
  • Country
  • BOLT United States
  • GRRR United Kingdom
  • Employees
  • BOLT N/A
  • GRRR 142
  • Industry
  • BOLT Biotechnology: Pharmaceutical Preparations
  • GRRR Computer Software: Prepackaged Software
  • Sector
  • BOLT Health Care
  • GRRR Technology
  • Exchange
  • BOLT Nasdaq
  • GRRR Nasdaq
  • Market Cap
  • BOLT 25.3M
  • GRRR 47.8M
  • IPO Year
  • BOLT 2021
  • GRRR N/A
  • Fundamental
  • Price
  • BOLT $0.57
  • GRRR $4.12
  • Analyst Decision
  • BOLT Hold
  • GRRR Buy
  • Analyst Count
  • BOLT 5
  • GRRR 1
  • Target Price
  • BOLT $1.25
  • GRRR $9.00
  • AVG Volume (30 Days)
  • BOLT 126.9K
  • GRRR 582.0K
  • Earning Date
  • BOLT 11-12-2024
  • GRRR 11-29-2024
  • Dividend Yield
  • BOLT N/A
  • GRRR N/A
  • EPS Growth
  • BOLT N/A
  • GRRR N/A
  • EPS
  • BOLT N/A
  • GRRR 2.28
  • Revenue
  • BOLT $9,779,000.00
  • GRRR $78,940,347.00
  • Revenue This Year
  • BOLT $16.30
  • GRRR $15.59
  • Revenue Next Year
  • BOLT N/A
  • GRRR $20.59
  • P/E Ratio
  • BOLT N/A
  • GRRR $1.81
  • Revenue Growth
  • BOLT 35.86
  • GRRR 424.97
  • 52 Week Low
  • BOLT $0.55
  • GRRR $2.09
  • 52 Week High
  • BOLT $1.56
  • GRRR $13.00
  • Technical
  • Relative Strength Index (RSI)
  • BOLT 29.99
  • GRRR 46.04
  • Support Level
  • BOLT $0.63
  • GRRR $4.23
  • Resistance Level
  • BOLT $0.69
  • GRRR $4.79
  • Average True Range (ATR)
  • BOLT 0.03
  • GRRR 0.31
  • MACD
  • BOLT -0.01
  • GRRR -0.05
  • Stochastic Oscillator
  • BOLT 3.49
  • GRRR 8.22

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About GRRR Gorilla Technology Group Inc. Ordinary shares

Gorilla Technology Group Inc is primarily engaged in providing information, software, and data processing services. It is a provider of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology (OT) security solutions and services. Its reportable segments are video IoT and security convergence and Other segments.

Share on Social Networks: